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It was the helium-filled balloons floating in the air during the 1959 International Workers’ Day
in Moscow that first inspired Dr. Serbinenko to navigate from the common carotid artery to
the intracranial circulation (1). He achieved that on February 8, 1964, by performing the first
selective extracranial carotid injection with the assistance of temporary balloon for internal carotid
artery occlusion. This was followed by the selective catheterization of the intracranial circulation
using a flow-directed balloon catheter. Shortly after, he successfully treated a carotid-cavernous
fistula (December 15, 1969) using a detachable balloon (1), marking the birth of our specialty:
Neurointerventional Surgery.
Balloon catheters are no longer needed to achieve selective intracranial catheterization, but their
therapeutic role has expanded significantly. Building upon the success of balloon angioplasty and
balloon-mounted stents in the cardiology literature, Neurointerventionalists began using them
intracranially, first for atherosclerotic stenosis (2), and then as an adjunct to coiling (3). Over the
last 20 years, the applications and successes of these various balloons and stents have significantly
expanded.We aim in this research topic to highlight the different trends being practiced today, some
of which have the potential to become an integral part of our practice, while others may fade away.
The advent of aneurysm coiling (stand-alone coiling) has permanently changed the treatment of
intracranial aneurysms, despite its limitations. The balloon remodeling technique (BRT) was first
introduced in 1997 (3) and was followed by the stent-assisted coiling technique (SACT). Each has
dramatically expanded the impact of aneurysm coiling, by allowing us to treat wide-neck aneurysms.
Relying on their extensive experience, Dr. Piotin et al. detailed both BRT and SACT (4). They
presented us with their mature technique and strategy concerning the use of each modality and
device.
The different coiling techniques, however, suffer from two main shortcomings: aneurysm recur-
rence and an inability to treat giant aneurysms. Flow-diverters (FD)were recently invented to address
these issues, for which Dr. Zanaty et al. gave a detailed introduction (5). Stemming from their title
“Flow-Diversion Panacea or Poison?” it is apparent that there are still many questions about this
technique, which they admirably try to address.
Another source of doubt and controversy in the care of subarachnoid hemorrhage patients is
vasospasm prevention and treatment. Although it was first angiographically described in 1950 (6,
7), it is still a significant source of delayed morbidity and mortality. Dr. Bauer et al. detailed, in this
research topic, the different methods of prevention and treatment as well as the controversy, but
thankfully left us with clear and practical recommendations for day-to-day practice (8).
On another note, our knowledge of intracranial atherosclerotic disease (ICAD) is very limited,
despite its prevalence, as Pu et al. highlighted in their review article. They emphasize, and rightly
so, the stroke risk difference between symptomatic (approximately 10% per year) and asymptomatic
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ICAD (on the order of 3%) and the dynamic nature of the disease
(9). Significant research on this subject is still needed.
Unfortunately, and despite its health burden worldwide, we still
do not have a suitable treatment for ICAD. The EC-IC Bypass
and SAMMPRIS trials failed to prove the benefits of surgical or
endovascular treatments.We believe, however, that progress is still
possible, especially in the pharmacology and endovascular realms.
The authors of this research topic have already published some of
the largest studies to date, relying on their extensive clinical expe-
rience. Concurrent with our distinguished panel, we believe that
the reasons the endovascular treatment arm of the SAMMPRIS
trial failed to show benefits are multifactorial, most of which can
be corrected. First, the technique used was notmeticulous enough
as Connors et al. discuss in their paper here. They emphasize the
importance of their previously described method (Slow Inflation
Undersized Balloon Technique) in reducing technical complication
rates (10). Second, only one device was allowed in the SAMMRIS
trial (The Wingspan™, Stryker, Kalamazoo, MI, USA). McTaggart
et al. argue in their paper in this research topic for intracranial
“angioplasty alone” technique, mainly due to its safety profile in
most cases (11), especially when coupled with Connors’ technique
(10). Third, Miao presents, in his paper here, yet another critique
to improve the SAMMPRIS trial results, where all lesions were
treated identically (12). He successfully argues that each lesion is
unique and should be treated differently, mainly based on lesion
morphologies (different lesion, different device). For example, a
concentric and short lesion could be treated by angioplasty alone,
while other lesions need a more complex device. His “Complex
Strategy” is very intriguing indeed.
Farooq et al. present a synthesis about the overall strategy of
endovascular treatment regarding ICAD (13). They try to incor-
porate all authors’ recommendations, while placing an emphasis
on the guiding catheter position “the closer to the lesion, the better.”
They conclude with the assessment that a new trial, incorporating
all these critiques and recommendations, is needed.
The final chapter of this research topic addresses acute ischemic
stroke treatment. Al-Ali et al. argue that the presence or absence
of collaterals (Circle of Willis and pial collaterals) determines the
clinical outcome more than time from ictus to revascularization
(14, 15): “collaterals, not time, is brain.” They argue for the use
of the capillary index score (CIS) rather than an arbitrary time
window to select patients for endovascular treatment. The CIS
presumably reflects the percentage of viable tissue in the ischemic
area, while its absence indicates non-viable tissue. The possibility
that genetic factors play a determining role in the extent of collat-
erals, as emphasized byDr. Faber (14), is a very exciting hypothesis
and if proven will significantly impact the way we understand and
treat ischemic strokes.
While in this research topic, we aim to present a synthesis of
certain techniques practiced today; our true aim is to challenge
our esteemed colleagues worldwide by raising more questions.
We believe in their abilities and in the future of our promising
specialty.
ACKNOWLEDGMENTS
We acknowledgeDr. John J. Elias, Clare Scantling, and ZeinAl-Ali
for their help in the drafting and editing of this preface.
REFERENCES
1. Teitelbaum GP, Larsen DW, Zelman V, Lysachev AG, Likhterman LB. A tribute
to Dr. Fedor A. Serbinenko, founder of endovascular neurosurgery. Neuro-
surgery (2000) 46.2:462–70. doi:10.1097/00006123-200002000-00037
2. Sundt TM Jr, Smith HC, Campbell JK. Transluminal angioplasty for basilar
artery stenosis.Mayo Clin Proc (1980) 55:673–80.
3. Moret J, Cognard C, Weill A, Castaings L, Rey A. The “remodelling technique”
in the treatment of wide neck intracranial aneurysms. Angiographic results and
clinical follow-up in 56 cases. Interv Neuroradiol (1997) 3:21–35.
4. PiotinM, Blanc R. Balloons and stents in the endovascular treatment of cerebral
aneurysms: vascular anatomy remodeled. Front Neurol (2014) 5:41. doi:10.
3389/fneur.2014.00041
5. ZanatyM, Chalouhi N, Tjoumakaris SI, Rosenwasser RH, Gonzalez LF, Jabbour
P. Flow-diversion panacea or poison? Front Neurol (2014) 5:21. doi:10.3389/
fneur.2014.00021
6. Reid JA, Johnson ON. SIXTH International Congress of Radiology; 1950. Radio-
graphy (1949) 15(180):282.
7. Ecker A, Riemenschneider PA. Arteriographic demonstration of spasm of
the intracranial arteries, with special reference to saccular arterial aneurysms.
J Neurosurg (1951) 8(6):660–7. doi:10.3171/jns.1951.8.6.0660
8. Bauer AM, Rasmussen PA. Treatment of intracranial vasospasm following sub-
arachnoid hemorrhage. FrontNeurol (2014) 5:72. doi:10.3389/fneur.2014.00072
9. Pu Y, Dou X, Liu L. Natural history of intracranial atherosclerotic disease. Front
Neurol (2014) 5:125. doi:10.3389/fneur.2014.00125
10. Connors JJ III, Wojak JC, Hoppe BH. The technique of endovascular intracra-
nial revascularization. Front Neurol (2014) 5:246. doi:10.3389/fneur.2014.00246
11. McTaggart RA, Marks MP. The case for angioplasty in patients with symp-
tomatic intracranial atherosclerosis. Front Neurol (2014) 5:36. doi:10.3389/
fneur.2014.00036
12. Miao Z. Intracranial angioplasty and stenting before and after SAMMPRIS:
“from simple to complex strategy – theChinese experience”. Front Neurol (2014)
5:129. doi:10.3389/fneur.2014.00129
13. Farooq MU, Al-Ali F, Min J, Gorelick PB. Reviving intracranial angioplasty
and stenting “SAMMPRIS and beyond”. Front Neurol (2014) 5:101. doi:10.3389/
fneur.2014.00101
14. Al-Ali F, Elias JJ, Filipkowski DE, Faber JE. Acute ischemic stroke treatment,
part 1: patient selection “The 50% barrier and the capillary index score”. Front
Neurol (2015) 6:83. doi:10.3389/fneur.2015.00083
15. Al-Ali F, Elias JJ, Filipkowski DE. Acute ischemic stroke treatment, part 2:
treatment “Roles of capillary index score, revascularization and time”. Front
Neurol (2015) 6:117. doi:10.3389/fneur.2015.00117
Conflict of Interest Statement: The author declares that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2015 Al-Ali. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordancewith
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Neurology | www.frontiersin.org October 2015 | Volume 6 | Article 2182
